Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Atai Life Sciences N.V.

    NASDAQ: ATAI · Real-Time Price · USD
    2.19
    -0.06 (-2.67%)
    At close: Jun 27, 2025, 3:59 PM
    2.22
    1.14%
    After-hours: Jun 27, 2025, 05:30 PM EDT

    Atai Life Sciences Statistics

    Share Statistics

    Atai Life Sciences has 200.75M shares outstanding. The number of shares has increased by 18.46% in one year.

    Shares Outstanding

    n/a
    		 200.75M

    Shares Change (YoY)

    n/a
    		 18.46%

    Shares Change (QoQ)

    n/a
    		 18.18%

    Owned by Institutions (%)

    n/a
    		 9.05%

    Shares Floating

    n/a
    		 137.08M

    Failed to Deliver (FTD) Shares

    n/a
    		 4,432

    FTD / Avg. Volume

    n/a
    		 0.2%

    Short Selling Information

    The latest short interest is 11.55M, so 5.48% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 11.55M

    Short % of Shares Out

    n/a
    		 5.48%

    Short % of Float

    n/a
    		 7.05%

    Short Ratio (days to cover)

    n/a
    		 3.72

    Valuation Ratios

    The PE ratio is -1.43 and the forward PE ratio is -3.83. Atai Life Sciences's PEG ratio is -0.01.

    PE Ratio

    n/a
    		 -1.43

    Forward PE

    n/a
    		 -3.83

    PS Ratio

    n/a
    		 691.6

    Forward PS

    n/a
    		 0.9

    PB Ratio

    n/a
    		 1.83

    P/FCF Ratio

    n/a
    		 -2.58

    PEG Ratio

    n/a
    		 -0.01
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Atai Life Sciences.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 3.21, with a Debt / Equity ratio of 0.21.

    Current Ratio

    n/a
    		 3.21

    Quick Ratio

    n/a
    		 3.21

    Debt / Equity

    n/a
    		 0.21

    Debt / EBITDA

    n/a
    		 -0.17

    Debt / FCF

    n/a
    		 -0.3

    Interest Coverage

    n/a
    		 -32.87

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $5,703.7

    Profits Per Employee

    n/a
    		 $-2,764,240.74

    Employee Count

    n/a
    		 54

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 -356K

    Effective Tax Rate

    n/a
    		 0.24%

    Stock Price Statistics

    The stock price has increased by 69.7% in the last 52 weeks. The beta is 1.48, so Atai Life Sciences's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.48

    52-Week Price Change

    n/a
    		 69.7%

    50-Day Moving Average

    n/a
    		 1.87

    200-Day Moving Average

    n/a
    		 1.56

    Relative Strength Index (RSI)

    n/a
    		 54.36

    Average Volume (20 Days)

    n/a
    		 2,191,941

    Income Statement

    In the last 12 months, Atai Life Sciences had revenue of 308K and earned -149.27M in profits. Earnings per share was -0.93.

    Revenue

    n/a
    		 308K

    Gross Profit

    n/a
    		 1.55M

    Operating Income

    n/a
    		 -102.69M

    Net Income

    n/a
    		 -149.27M

    EBITDA

    n/a
    		 -145.33M

    EBIT

    n/a
    		 -145.28M

    Earnings Per Share (EPS)

    n/a
    		 -0.93
    Full Income Statement

    Balance Sheet

    The company has 17.5M in cash and 24.71M in debt, giving a net cash position of -7.2M.

    Cash & Cash Equivalents

    n/a
    		 17.5M

    Total Debt

    n/a
    		 24.71M

    Net Cash

    n/a
    		 -7.2M

    Retained Earnings

    n/a
    		 -700.21M

    Total Assets

    n/a
    		 195.78M

    Working Capital

    n/a
    		 87.48M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -82.44M and capital expenditures -95K, giving a free cash flow of -82.53M.

    Operating Cash Flow

    n/a
    		 -82.44M

    Capital Expenditures

    n/a
    		 -95K

    Free Cash Flow

    n/a
    		 -82.53M

    FCF Per Share

    n/a
    		 -0.52
    Full Cash Flow Statement

    Margins

    Gross margin is 504.87%, with operating and profit margins of -33341.23% and -48463.96%.

    Gross Margin

    n/a
    		 504.87%

    Operating Margin

    n/a
    		 -33341.23%

    Pretax Margin

    n/a
    		 -48183.44%

    Profit Margin

    n/a
    		 -48463.96%

    EBITDA Margin

    n/a
    		 -47186.04%

    EBIT Margin

    n/a
    		 -33341.23%

    FCF Margin

    n/a
    		 -26796.1%

    Dividends & Yields

    ATAI does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for ATAI is $10.5, which is 368.7% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $10.5

    Price Target Difference

    n/a
    		 368.7%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 2
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 -0.73

    Piotroski F-Score

    n/a
    		 4

    Add to Watchlist